Your browser doesn't support javascript.
loading
Evolution of retinal degeneration and prediction of disease activity in relapsing and progressive multiple sclerosis.
Krämer, Julia; Balloff, Carolin; Weise, Margit; Koska, Valeria; Uthmeier, Yannik; Esderts, Isabell; Nguyen-Minh, Mai; Zimmerhof, Moritz; Hartmann, Alex; Dietrich, Michael; Ingwersen, Jens; Lee, John-Ih; Havla, Joachim; Kümpfel, Tania; Kerschensteiner, Martin; Häußler, Vivien; Heesen, Christoph; Stellmann, Jan-Patrick; Zimmermann, Hanna G; Oertel, Frederike C; Ringelstein, Marius; Brandt, Alexander U; Paul, Friedemann; Aktas, Orhan; Hartung, Hans-Peter; Wiendl, Heinz; Meuth, Sven G; Albrecht, Philipp.
Affiliation
  • Krämer J; Department of Neurology with Institute of Translational Neurology, University Hospital Münster, Münster, Germany. julia.kraemer@ukmuenster.de.
  • Balloff C; Department of Neurology, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
  • Weise M; Department of Neurology, Kliniken Maria Hilf, Mönchengladbach, Germany.
  • Koska V; Department of Neurology, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
  • Uthmeier Y; Department of Neurology, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
  • Esderts I; Department of Neurology, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
  • Nguyen-Minh M; Department of Neurology with Institute of Translational Neurology, University Hospital Münster, Münster, Germany.
  • Zimmerhof M; Department of Neurology with Institute of Translational Neurology, University Hospital Münster, Münster, Germany.
  • Hartmann A; Department of Neurology with Institute of Translational Neurology, University Hospital Münster, Münster, Germany.
  • Dietrich M; Hanseatic Statistics, Hamburg, Germany.
  • Ingwersen J; Department of Neurology, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
  • Lee JI; Department of Neurology, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
  • Havla J; Department of Neurology, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
  • Kümpfel T; Institute of Clinical Neuroimmunology, LMU Hospital, Ludwig-Maximilians University München, München, Germany.
  • Kerschensteiner M; Institute of Clinical Neuroimmunology, LMU Hospital, Ludwig-Maximilians University München, München, Germany.
  • Häußler V; Institute of Clinical Neuroimmunology, LMU Hospital, Ludwig-Maximilians University München, München, Germany.
  • Heesen C; Biomedical Center, Faculty of Medicine, Ludwig-Maximilians University München, München, Germany.
  • Stellmann JP; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.
  • Zimmermann HG; Institute of Neuroimmunology and Multiple Sclerosis (INIMS), University Hospital Hamburg-Eppendorf, Hamburg, Germany.
  • Oertel FC; Department of Neurology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
  • Ringelstein M; Institute of Neuroimmunology and Multiple Sclerosis (INIMS), University Hospital Hamburg-Eppendorf, Hamburg, Germany.
  • Brandt AU; Department of Neurology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
  • Paul F; Institute of Neuroimmunology and Multiple Sclerosis (INIMS), University Hospital Hamburg-Eppendorf, Hamburg, Germany.
  • Aktas O; Department of Neurology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
  • Hartung HP; Aix-Marseille University, CNRS-CRMBM, UMR, 7339, Marseille, France.
  • Wiendl H; APHM La Timone, CEMEREM, Marseille, France.
  • Meuth SG; Experimental and Clinical Research Center, Max-Delbrück Center for Molecular Medicine and Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Albrecht P; Experimental and Clinical Research Center, Max-Delbrück Center for Molecular Medicine and Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Nat Commun ; 15(1): 5243, 2024 Jun 19.
Article in En | MEDLINE | ID: mdl-38897994
ABSTRACT
Retinal optical coherence tomography has been identified as biomarker for disease progression in relapsing-remitting multiple sclerosis (RRMS), while the dynamics of retinal atrophy in progressive MS are less clear. We investigated retinal layer thickness changes in RRMS, primary and secondary progressive MS (PPMS, SPMS), and their prognostic value for disease activity. Here, we analyzed 2651 OCT measurements of 195 RRMS, 87 SPMS, 125 PPMS patients, and 98 controls from five German MS centers after quality control. Peripapillary and macular retinal nerve fiber layer (pRNFL, mRNFL) thickness predicted future relapses in all MS and RRMS patients while mRNFL and ganglion cell-inner plexiform layer (GCIPL) thickness predicted future MRI activity in RRMS (mRNFL, GCIPL) and PPMS (GCIPL). mRNFL thickness predicted future disability progression in PPMS. However, thickness change rates were subject to considerable amounts of measurement variability. In conclusion, retinal degeneration, most pronounced of pRNFL and GCIPL, occurs in all subtypes. Using the current state of technology, longitudinal assessments of retinal thickness may not be suitable on a single patient level.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Retina / Retinal Degeneration / Disease Progression / Multiple Sclerosis, Chronic Progressive / Multiple Sclerosis, Relapsing-Remitting / Tomography, Optical Coherence Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Nat Commun Year: 2024 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Retina / Retinal Degeneration / Disease Progression / Multiple Sclerosis, Chronic Progressive / Multiple Sclerosis, Relapsing-Remitting / Tomography, Optical Coherence Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Nat Commun Year: 2024 Document type: Article